Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of diclofenac and vitamin B12 is a therapeutic approach used primarily for pain management, particularly for conditions involving both nociceptive and neuropathic pain components. This combination has shown synergistic effects in multiple clinical studies. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that works primarily by inhibiting cyclooxygenase enzymes, reducing inflammation and pain. Vitamin B12 (cyanocobalamin) is an essential nutrient that plays crucial roles in nerve function, cell metabolism, and DNA synthesis. When combined, these components demonstrate enhanced analgesic effects compared to diclofenac alone. Research indicates that vitamin B12 potentiates the analgesic effect of diclofenac, allowing for potentially lower doses of the NSAID while maintaining or improving pain relief[1][3]. The combination appears particularly effective for conditions involving nerve damage or neuropathic pain components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diclofenac + vitamin B12.